NexGelNXGL +0.70%60 Days Payable is 88.87 as of Mar. 2026, which is 25% above its 10-year median of 70.87. GuruFocus rates NXGL with a GF Score™ of 60/100 and a GF Value™ of $4.38 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 796 Medical Devices & Instruments companies, NexGel ranks better than 54.27% on this metric.
NexGel's average Accounts Payable for the
three
months ended in Mar. 2026 was $1.55 Mil. NexGel's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $1.59 Mil.
Hence, NexGel's Days Payable for the
three
months ended in Mar. 2026 was 88.87.
The historical rank and industry rank for NexGel's Days Payable or its related term are showing as below:
NXGL'
s Days Payable Range Over the Past 10 Years
Min: 20.77 Med: 70.87 Max: 220.89
Current: 74.91
During the past 10 years, NexGel's highest Days Payable was 220.89. The lowest was 20.77. And the median was 70.87.
NXGL's Days Payable is ranked better than 54.27% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs NXGL: 74.91
NexGel's Days Payable
increased
from Mar. 2025 (78.14) to Mar. 2026 (88.87).
It may suggest that NexGeldelayed paying its suppliers.
NexGel Days Payable Related Terms
NexGel Days Payable Historical Data
* Premium members only.
The historical data trend for NexGel's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, NexGel's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NexGel Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NexGel's Days Payable distribution charts can be found below:
* The bar in red indicates where NexGel's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
NexGel's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NexGel (NXGL) has a Days Payable of 88.87 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NexGel and its competitors. This is 25% above median its historical median of 70.87. Over the past decade, NexGel's Days Payable has ranged from 20.77 to 220.89. According to the industry distribution chart, NexGel ranks #364 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 45.7%.
Is NexGel's Days Payable too high?
NexGel's current Days Payable of 88.87 is 25% above median its 10-year median of 70.87. Over the past 10 years, this metric has ranged from a low of 20.77 to a high of 220.89. The Medical Devices & Instruments industry median Days Payable is 67.97. NexGel's value of 88.87 is 30.7% above this industry median. Based on the distribution chart, NexGel ranks #364 out of 796 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, NexGel has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does NexGel's Days Payable compare to LUCY and CBSC?
According to the Medical Devices & Instruments industry distribution chart, NexGel ranks #364 out of 796 companies for Days Payable. This puts NexGel in the upper half of its industry. The industry median Days Payable is 67.97. NexGel's value of 88.87 is 30.7% above this benchmark. Historically, NexGel's own Days Payable has ranged from 20.77 to 220.89 over the past decade. While the company's 10-year median is 70.87 vs. the industry median of 67.97, NexGel has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NexGel's current Days Payable of 88.87 is 30.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NexGel and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NexGel's current Days Payable is 88.87, which is 25% above median its own 10-year median of 70.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NexGel stock overvalued right now?
Based on GuruFocus' analysis, NexGel (NXGL) is currently considered Possible Value Trap. The stock's GF Value™ is $4.38, compared to a current price of $0.51 — trading 88.3% below its estimated fair value. The current Days Payable is 88.87, which is 25% above median its 10-year median of 70.87 and 30.7% above the Medical Devices & Instruments industry median of 67.97. NexGel's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For NexGel (NXGL), the current Days Payable is 88.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NexGel (NXGL) Overvalued in 2026?
Based on GuruFocus' analysis, NexGel stock appears to be undervalued.
The current stock price of $0.51 is trading 88.3% below its estimated GF Value™ of $4.38.
GuruFocus considers NexGel to be Possible Value Trap.
Key valuation signals for NXGL:
Days Payable: 88.87 (25% above median its 10-year median of 70.87)
GF Value™: $4.38 vs. price of $0.51 (88.3% below fair value)
Industry Position: 30.7% above the Medical Devices & Instruments median (#364 of 796)
No single metric tells the full story. See the NXGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
60GF Score
Get the complete analysis for NXGL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NXGL has been successfully added to your 
